GPD1L and hepatocellular carcinoma: Activation of the AMPK pathway can inhibit HCC cell proliferation and induce cell cycle arrest, suggesting that the dysregulation of GPD1L-mediated AMPK signalling may contribute to HCC development and progression [26,27].